Nelaj, E., I. Kecaj, J. Feracaku, K. Xhixhabesi, and M. Tase. “Benefits of SGLT2 Inhibitors on Renal and Cardiovascular Protection, in Diabetic Patients”. South Eastern European Journal of Public Health, Aug. 2024, pp. 200-6, doi:10.70135/seejph.vi.689.